CPG
HZNP

Cornerstone Planning Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Cornerstone Planning Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2
Closed -$231 – 1047
2023
Q3 		$231 Buy
+2
New +$215 ﹤0.01% 1012
2022
Q4 		$2.26K Buy
+20
New +$1.66K ﹤0.01% 1152

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cornerstone Planning Group's HZNP Position: Q4 2023 in Review

Cornerstone Planning Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2 shares — an estimated $231 sold.

Cornerstone Planning Group first reported a position in HZNP in Q4 2022 and held it in 2 quarters. The position peaked at $2.26K in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Cornerstone Planning Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Cornerstone Planning Group sold 2 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $231.
  • Cornerstone Planning Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022 and held it in 2 quarters.
  • Cornerstone Planning Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.26K in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Cornerstone Planning Group's 13F filing for Q4 2023, filed 12 Feb 2024.